Sarepta Therapeutics, Inc. (SRPT)
USD 51.38
(-5.6%)
USD 51.38
(-5.6%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -267.82 Million USD | 50.05% |
| 2022 | -536.2 Million USD | -19.23% |
| 2021 | -449.71 Million USD | 20.29% |
| 2020 | -564.16 Million USD | -8.01% |
| 2019 | -522.32 Million USD | -52.0% |
| 2018 | -343.62 Million USD | -100.21% |
| 2017 | -171.63 Million USD | 35.65% |
| 2016 | -266.73 Million USD | -21.14% |
| 2015 | -220.18 Million USD | -64.58% |
| 2014 | -133.78 Million USD | -48.19% |
| 2013 | -90.28 Million USD | -203.96% |
| 2012 | -29.7 Million USD | 17.32% |
| 2011 | -35.92 Million USD | -71.62% |
| 2010 | -20.93 Million USD | -35.0% |
| 2009 | -15.5 Million USD | 43.52% |
| 2008 | -27.45 Million USD | 17.07% |
| 2007 | -33.1 Million USD | -0.38% |
| 2006 | -32.98 Million USD | -88.3% |
| 2005 | -17.51 Million USD | 30.06% |
| 2004 | -25.04 Million USD | -32.69% |
| 2003 | -18.87 Million USD | 25.52% |
| 2002 | -25.34 Million USD | -64.52% |
| 2001 | -15.4 Million USD | -50.4% |
| 2000 | -10.24 Million USD | -23.39% |
| 1999 | -8.3 Million USD | -7.79% |
| 1998 | -7.7 Million USD | -97.44% |
| 1997 | -3.9 Million USD | -77.27% |
| 1996 | -2.2 Million USD | 15.38% |
| 1995 | -2.6 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 34.9 Million USD | 41.75% |
| 2024 Q2 | -701 Thousand USD | -102.01% |
| 2023 Q2 | -133.51 Million USD | 3.31% |
| 2023 FY | -267.82 Million USD | 50.05% |
| 2023 Q4 | 24.62 Million USD | 218.15% |
| 2023 Q1 | -138.08 Million USD | -29.26% |
| 2023 Q3 | -20.84 Million USD | 84.39% |
| 2022 FY | -536.2 Million USD | -19.23% |
| 2022 Q4 | -106.83 Million USD | 18.67% |
| 2022 Q3 | -131.35 Million USD | 37.79% |
| 2022 Q1 | -86.88 Million USD | 17.89% |
| 2022 Q2 | -211.13 Million USD | -143.01% |
| 2021 FY | -449.71 Million USD | 20.29% |
| 2021 Q1 | -151.86 Million USD | 11.04% |
| 2021 Q2 | -167.57 Million USD | -10.34% |
| 2021 Q3 | -34.45 Million USD | 79.44% |
| 2021 Q4 | -105.81 Million USD | -207.08% |
| 2020 Q3 | -137.06 Million USD | 0.93% |
| 2020 Q2 | -138.35 Million USD | -17.22% |
| 2020 FY | -564.16 Million USD | -8.01% |
| 2020 Q1 | -118.02 Million USD | 48.73% |
| 2020 Q4 | -170.71 Million USD | -24.55% |
| 2019 Q4 | -230.21 Million USD | -86.28% |
| 2019 Q2 | -275.36 Million USD | -260.49% |
| 2019 Q3 | -123.59 Million USD | 55.12% |
| 2019 Q1 | -76.38 Million USD | 45.19% |
| 2019 FY | -522.32 Million USD | -52.0% |
| 2018 Q2 | -103.42 Million USD | -236.47% |
| 2018 FY | -343.62 Million USD | -100.21% |
| 2018 Q4 | -139.36 Million USD | -98.81% |
| 2018 Q3 | -70.09 Million USD | 32.22% |
| 2018 Q1 | -30.73 Million USD | -32.8% |
| 2017 Q4 | -23.14 Million USD | 49.58% |
| 2017 FY | -171.63 Million USD | 35.65% |
| 2017 Q1 | -39.24 Million USD | 55.6% |
| 2017 Q2 | -63.33 Million USD | -61.39% |
| 2017 Q3 | -45.9 Million USD | 27.52% |
| 2016 Q3 | -56.53 Million USD | 8.96% |
| 2016 FY | -266.73 Million USD | -21.14% |
| 2016 Q1 | -59.7 Million USD | 7.37% |
| 2016 Q4 | -88.39 Million USD | -56.36% |
| 2016 Q2 | -62.1 Million USD | -4.02% |
| 2015 Q3 | -51.76 Million USD | -22.93% |
| 2015 FY | -220.18 Million USD | -64.58% |
| 2015 Q1 | -61.86 Million USD | -38.33% |
| 2015 Q2 | -42.1 Million USD | 31.93% |
| 2015 Q4 | -64.45 Million USD | -24.51% |
| 2014 FY | -133.78 Million USD | -48.19% |
| 2014 Q2 | -30.27 Million USD | -20.5% |
| 2014 Q1 | -25.12 Million USD | 23.53% |
| 2014 Q3 | -33.67 Million USD | -11.25% |
| 2014 Q4 | -44.72 Million USD | -32.8% |
| 2013 Q2 | -17.08 Million USD | -10.85% |
| 2013 Q1 | -15.41 Million USD | -48.69% |
| 2013 Q3 | -24.93 Million USD | -45.92% |
| 2013 Q4 | -32.84 Million USD | -31.75% |
| 2013 FY | -90.28 Million USD | -203.96% |
| 2012 Q3 | -6.9 Million USD | -24.26% |
| 2012 FY | -29.7 Million USD | 17.32% |
| 2012 Q2 | -5.55 Million USD | 19.16% |
| 2012 Q1 | -6.87 Million USD | 23.62% |
| 2012 Q4 | -10.36 Million USD | -50.14% |
| 2011 Q2 | -10.12 Million USD | -83.06% |
| 2011 FY | -35.92 Million USD | -71.62% |
| 2011 Q3 | -11.27 Million USD | -11.32% |
| 2011 Q4 | -9 Million USD | 20.15% |
| 2011 Q1 | -5.53 Million USD | -217.87% |
| 2010 Q3 | -3.79 Million USD | 50.48% |
| 2010 Q2 | -7.66 Million USD | 0.88% |
| 2010 Q1 | -7.73 Million USD | -95.62% |
| 2010 Q4 | -1.74 Million USD | 54.17% |
| 2010 FY | -20.93 Million USD | -35.0% |
| 2009 Q3 | -2.92 Million USD | 42.27% |
| 2009 FY | -15.5 Million USD | 43.52% |
| 2009 Q1 | -3.56 Million USD | -23.2% |
| 2009 Q2 | -5.06 Million USD | -42.08% |
| 2009 Q4 | -3.95 Million USD | -35.23% |
| 2008 Q4 | -2.89 Million USD | 51.27% |
| 2008 FY | -27.45 Million USD | 17.07% |
| 2008 Q2 | -4.87 Million USD | 64.51% |
| 2008 Q1 | -13.74 Million USD | -142.53% |
| 2008 Q3 | -5.93 Million USD | -21.72% |
| 2007 Q3 | -8.51 Million USD | 3.69% |
| 2007 Q1 | -10.08 Million USD | -14.97% |
| 2007 FY | -33.1 Million USD | -0.38% |
| 2007 Q4 | -5.66 Million USD | 33.42% |
| 2007 Q2 | -8.84 Million USD | 12.35% |
| 2006 Q3 | -7.27 Million USD | 1.97% |
| 2006 Q2 | -7.41 Million USD | 22.06% |
| 2006 Q1 | -9.51 Million USD | -94.06% |
| 2006 FY | -32.98 Million USD | -88.3% |
| 2006 Q4 | -8.77 Million USD | -20.62% |
| 2005 Q1 | -5.54 Million USD | -12.32% |
| 2005 Q4 | -4.9 Million USD | -155.79% |
| 2005 Q3 | -1.91 Million USD | 62.75% |
| 2005 Q2 | -5.14 Million USD | 7.16% |
| 2005 FY | -17.51 Million USD | 30.06% |
| 2004 Q1 | -7.75 Million USD | -8.3% |
| 2004 Q3 | -5.12 Million USD | 29.16% |
| 2004 Q4 | -4.93 Million USD | 3.63% |
| 2004 Q2 | -7.23 Million USD | 6.72% |
| 2004 FY | -25.04 Million USD | -32.69% |
| 2003 Q3 | -4.67 Million USD | -31.67% |
| 2003 Q2 | -3.55 Million USD | -2.08% |
| 2003 Q1 | -3.48 Million USD | 16.15% |
| 2003 FY | -18.87 Million USD | 25.52% |
| 2003 Q4 | -7.15 Million USD | -52.98% |
| 2002 Q4 | -4.15 Million USD | 22.7% |
| 2002 Q1 | -7.89 Million USD | -66.87% |
| 2002 Q2 | -7.92 Million USD | -0.33% |
| 2002 Q3 | -5.37 Million USD | 32.2% |
| 2002 FY | -25.34 Million USD | -64.52% |
| 2001 Q3 | -3.34 Million USD | 11.62% |
| 2001 Q1 | -3.54 Million USD | -2.53% |
| 2001 Q2 | -3.78 Million USD | -6.9% |
| 2001 Q4 | -4.73 Million USD | -41.46% |
| 2001 FY | -15.4 Million USD | -50.4% |
| 2000 FY | -10.24 Million USD | -23.39% |
| 2000 Q2 | -2.95 Million USD | -138.25% |
| 2000 Q1 | -1.24 Million USD | 48.31% |
| 2000 Q3 | -2.59 Million USD | 12.34% |
| 2000 Q4 | -3.45 Million USD | -33.28% |
| 1999 Q4 | -2.4 Million USD | -14.29% |
| 1999 FY | -8.3 Million USD | -7.79% |
| 1999 Q1 | -1.6 Million USD | 36.0% |
| 1999 Q3 | -2.1 Million USD | -10.53% |
| 1999 Q2 | -1.9 Million USD | -18.75% |
| 1998 Q2 | -1.7 Million USD | -13.33% |
| 1998 Q3 | -1.8 Million USD | -5.88% |
| 1998 FY | -7.7 Million USD | -97.44% |
| 1998 Q4 | -2.5 Million USD | -38.89% |
| 1998 Q1 | -1.5 Million USD | -50.0% |
| 1997 Q1 | -600 Thousand USD | 16.67% |
| 1997 Q3 | -900 Thousand USD | 25.0% |
| 1997 FY | -3.9 Million USD | -77.27% |
| 1997 Q4 | -1 Million USD | -11.11% |
| 1997 Q2 | -1.2 Million USD | -100.0% |
| 1996 Q3 | -590 Thousand USD | 0.0% |
| 1996 FY | -2.2 Million USD | 15.38% |
| 1996 Q1 | -430 Thousand USD | 0.0% |
| 1996 Q4 | -720 Thousand USD | -22.03% |
| 1996 Q2 | -590 Thousand USD | -37.21% |
| 1995 FY | -2.6 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| AbCellera Biologics Inc. | -237.2 Million USD | -12.907% |
| Alkermes plc | 414.12 Million USD | 164.673% |
| Agenus Inc. | -159.54 Million USD | -67.863% |
| Aptorum Group Limited | -10.52 Million USD | -2445.05% |
| Ardelyx, Inc. | -63.27 Million USD | -323.263% |
| Dyadic International, Inc. | -8.22 Million USD | -3154.344% |
| Eton Pharmaceuticals, Inc. | -1.19 Million USD | -22368.456% |
| Lantern Pharma Inc. | -17.87 Million USD | -1398.101% |
| Inhibikase Therapeutics, Inc. | -20.08 Million USD | -1233.135% |
| Novavax, Inc. | -566.51 Million USD | 52.724% |
| Janux Therapeutics, Inc. | -72.97 Million USD | -266.988% |
| Pyxis Oncology, Inc. | -82.19 Million USD | -225.836% |
| TransCode Therapeutics, Inc. | -19.41 Million USD | -1279.22% |
| Ocuphire Pharma, Inc. | -10.56 Million USD | -2435.492% |
| Outlook Therapeutics, Inc. | -53.12 Million USD | -404.126% |
| Madrigal Pharmaceuticals, Inc. | -380.49 Million USD | 29.612% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.3 Million USD | -1001.857% |
| SELLAS Life Sciences Group, Inc. | -37.86 Million USD | -607.238% |
| Syros Pharmaceuticals, Inc. | -128.98 Million USD | -107.635% |
| Barinthus Biotherapeutics plc | -83.91 Million USD | -219.165% |
| Windtree Therapeutics, Inc. | -17.53 Million USD | -1427.02% |
| Xeris Biopharma Holdings, Inc. | -44.01 Million USD | -508.553% |
| Clearside Biomedical, Inc. | -24.84 Million USD | -978.023% |
| C4 Therapeutics, Inc. | -139.03 Million USD | -92.636% |
| Alnylam Pharmaceuticals, Inc. | -282.17 Million USD | 5.086% |
| AlloVir, Inc. | -181.33 Million USD | -47.699% |
| Arrowhead Pharmaceuticals, Inc. | -205 Million USD | -30.645% |
| VYNE Therapeutics Inc. | -29.25 Million USD | -815.387% |
| Bicycle Therapeutics plc | -189.94 Million USD | -41.0% |
| BioXcel Therapeutics, Inc. | -171.78 Million USD | -55.909% |
| ChromaDex Corporation | -5.59 Million USD | -4683.426% |
| Chimerix, Inc. | -93.06 Million USD | -187.782% |
| Corbus Pharmaceuticals Holdings, Inc. | -45.07 Million USD | -494.144% |
| Caribou Biosciences, Inc. | -116.05 Million USD | -130.765% |
| CRISPR Therapeutics AG | -222.53 Million USD | -20.35% |
| Precision BioSciences, Inc. | -43.73 Million USD | -512.365% |
| Fate Therapeutics, Inc. | -190.51 Million USD | -40.582% |
| Fortress Biotech, Inc. | -142.34 Million USD | -88.155% |
| Fortress Biotech, Inc. | -142.34 Million USD | -88.155% |
| HOOKIPA Pharma Inc. | -97.69 Million USD | -174.146% |
| ImmuCell Corporation | -5.74 Million USD | -4559.366% |
| IDEAYA Biosciences, Inc. | -134.42 Million USD | -99.231% |
| Immix Biopharma, Inc. | -16.14 Million USD | -1559.266% |
| Incyte Corporation | 620.52 Million USD | 143.161% |
| Innoviva, Inc. | 176.7 Million USD | 251.562% |
| IO Biotech, Inc. | -91.44 Million USD | -192.886% |
| Jaguar Health, Inc. | -34.29 Million USD | -681.033% |
| Keros Therapeutics, Inc. | -169.94 Million USD | -57.598% |
| Ligand Pharmaceuticals Incorporated | 11.94 Million USD | 2342.706% |
| ContextLogic Inc. | -328 Million USD | 18.346% |
| MiMedx Group, Inc. | 37.11 Million USD | 821.586% |
| MEI Pharma, Inc. | 14.54 Million USD | 1941.727% |
| NextCure, Inc. | -67.63 Million USD | -295.973% |
| Onconetix, Inc. | -36.03 Million USD | -643.241% |
| Oncternal Therapeutics, Inc. | -41.71 Million USD | -542.048% |
| Opthea Limited | -191.84 Million USD | -39.606% |
| Psyence Biomedical Ltd. | -2.75 Million USD | -9632.596% |
| Vaxcyte, Inc. | -468.04 Million USD | 42.778% |
| PDS Biotechnology Corporation | -43.04 Million USD | -522.192% |
| Precigen, Inc. | -88.92 Million USD | -201.186% |
| Pharming Group N.V. | -4.87 Million USD | -5388.71% |
| Phathom Pharmaceuticals, Inc. | -167.31 Million USD | -60.075% |
| Pieris Pharmaceuticals, Inc. | -29.75 Million USD | -800.067% |
| PureTech Health plc | -146.19 Million USD | -83.191% |
| Rigel Pharmaceuticals, Inc. | -20.49 Million USD | -1207.032% |
| Avidity Biosciences, Inc. | -235.59 Million USD | -13.678% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.3 Million USD | -1001.857% |
| Sangamo Therapeutics, Inc. | -274 Million USD | 2.256% |
| Sol-Gel Technologies Ltd. | -29.3 Million USD | -813.919% |
| Acelyrin, Inc. | -422.06 Million USD | 36.544% |
| Salarius Pharmaceuticals, Inc. | -12.89 Thousand USD | -2076869.726% |
| Summit Therapeutics Inc. | -89.73 Million USD | -198.458% |
| Sensei Biotherapeutics, Inc. | -37.06 Million USD | -622.599% |
| Senti Biosciences, Inc. | -92.72 Million USD | -188.831% |
| Stoke Therapeutics, Inc. | -114.77 Million USD | -133.351% |
| Elevation Oncology, Inc. | -45.44 Million USD | -489.337% |
| Alaunos Therapeutics, Inc. | -34.26 Million USD | -681.58% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | -6694.032% |
| Entrada Therapeutics, Inc. | -3.16 Million USD | -8370.082% |
| VistaGen Therapeutics, Inc. | -33.02 Million USD | -711.072% |
| Kintara Therapeutics, Inc. | -8.5 Million USD | -3050.5% |
| Wave Life Sciences Ltd. | -67.99 Million USD | -293.882% |
| Seer, Inc. | -103.46 Million USD | -158.86% |
| Verrica Pharmaceuticals Inc. | -65.75 Million USD | -307.281% |
| Aadi Bioscience, Inc. | -71.93 Million USD | -272.324% |
| ESSA Pharma Inc. | -32.13 Million USD | -733.457% |
| GlycoMimetics, Inc. | -39.27 Million USD | -581.915% |
| GT Biopharma, Inc. | -13.57 Million USD | -1872.775% |
| Inhibrx Biosciences, Inc. | -219.22 Million USD | -22.171% |
| Akebia Therapeutics, Inc. | -46.25 Million USD | -479.004% |
| Catalyst Pharmaceuticals, Inc. | 86.81 Million USD | 408.51% |
| Longboard Pharmaceuticals, Inc. | -56.75 Million USD | -371.862% |
| Orchestra BioMed Holdings, Inc. | -51.5 Million USD | -419.986% |
| Alzamend Neuro, Inc. | -9.93 Million USD | -2595.045% |
| Sorrento Therapeutics, Inc. | -504.31 Million USD | 46.894% |
| TRACON Pharmaceuticals, Inc. | -6.89 Million USD | -3782.633% |
| Viracta Therapeutics, Inc. | -50.69 Million USD | -428.325% |
| Rocket Pharmaceuticals, Inc. | -259.65 Million USD | -3.145% |
| Aptose Biosciences Inc. | -52.35 Million USD | -411.544% |
| ZyVersa Therapeutics, Inc. | -14.42 Million USD | -1757.21% |
| Soligenix, Inc. | -7.69 Million USD | -3379.165% |
| Century Therapeutics, Inc. | -146.54 Million USD | -82.758% |
| Kura Oncology, Inc. | -165.8 Million USD | -61.53% |
| TScan Therapeutics, Inc. | -93.45 Million USD | -186.572% |
| Intensity Therapeutics, Inc. | -8.31 Million USD | -3119.425% |
| Ocean Biomedical, Inc. | -2.48 Million USD | -10692.222% |
| CytomX Therapeutics, Inc. | -6.48 Million USD | -4030.537% |
| Autolus Therapeutics plc | -195.02 Million USD | -37.326% |
| Mineralys Therapeutics, Inc. | -84.65 Million USD | -216.364% |
| EyePoint Pharmaceuticals, Inc. | -73.66 Million USD | -263.585% |
| Eterna Therapeutics Inc. | -21.13 Million USD | -1167.206% |
| Adaptive Biotechnologies Corporation | -227.03 Million USD | -17.966% |
| GRI Bio, Inc. | -11.38 Million USD | -2252.015% |
| Xenetic Biosciences, Inc. | -4.51 Million USD | -5830.932% |
| Tenaya Therapeutics, Inc. | -131.19 Million USD | -104.145% |
| IGM Biosciences, Inc. | -263.46 Million USD | -1.656% |
| INmune Bio, Inc. | -29.74 Million USD | -800.521% |
| Heron Therapeutics, Inc. | -110.61 Million USD | -142.123% |
| SAB Biotherapeutics, Inc. | -38.07 Million USD | -603.406% |
| Pasithea Therapeutics Corp. | -15.97 Million USD | -1576.062% |
| Entero Therapeutics, Inc. | -15.77 Million USD | -1598.224% |
| Milestone Pharmaceuticals Inc. | -61.09 Million USD | -338.352% |
| X4 Pharmaceuticals, Inc. | -107.52 Million USD | -149.088% |
| Atara Biotherapeutics, Inc. | -276 Million USD | 2.964% |
| Coherus BioSciences, Inc. | -203.19 Million USD | -31.804% |
| Verastem, Inc. | -92.08 Million USD | -190.847% |
| Abeona Therapeutics Inc. | -47.13 Million USD | -468.206% |
| Pliant Therapeutics, Inc. | -184.14 Million USD | -45.442% |
| Tonix Pharmaceuticals Holding Corp. | -118.38 Million USD | -126.241% |
| Histogen Inc. | -10.64 Million USD | -2416.433% |
| Aprea Therapeutics, Inc. | -15.47 Million USD | -1631.028% |
| Surrozen, Inc. | -45.78 Million USD | -485.024% |
| Organovo Holdings, Inc. | -15.08 Million USD | -1675.315% |
| Lixte Biotechnology Holdings, Inc. | -5.09 Million USD | -5161.524% |
| Ovid Therapeutics Inc. | -59.28 Million USD | -351.784% |
| Panbela Therapeutics, Inc. | -51.29 Million USD | -422.135% |
| CASI Pharmaceuticals, Inc. | -25.28 Million USD | -959.43% |
| Cadrenal Therapeutics, Inc. Common Stock | -7.63 Million USD | -3408.837% |
| Centessa Pharmaceuticals plc | -171.28 Million USD | -56.363% |
| Hepion Pharmaceuticals, Inc. | -48.44 Million USD | -452.808% |
| Arcturus Therapeutics Holdings Inc. | -78.2 Million USD | -242.464% |
| BioRestorative Therapies, Inc. | -15.22 Million USD | -1659.595% |
| Apollomics, Inc. | -54.83 Million USD | -388.427% |
| Amarin Corporation plc | -67.58 Million USD | -296.26% |
| Mesoblast Limited | -58.79 Million USD | -355.529% |
| Turnstone Biologics Corp. | -59.03 Million USD | -353.693% |
| Kymera Therapeutics, Inc. | -165.53 Million USD | -61.798% |
| Synaptogenix, Inc. | -8.31 Million USD | -3121.418% |
| Tiziana Life Sciences Ltd | -14.58 Million USD | -1736.172% |
| Aurinia Pharmaceuticals Inc. | -91.69 Million USD | -192.094% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -5489.605% |
| Monopar Therapeutics Inc. | -8.83 Million USD | -2932.69% |
| Exelixis, Inc. | 170.88 Million USD | 256.728% |
| Better Therapeutics, Inc. | -38.26 Million USD | -599.974% |
| Nurix Therapeutics, Inc. | -155.06 Million USD | -72.719% |
| Apellis Pharmaceuticals, Inc. | -517.12 Million USD | 48.209% |
| NLS Pharmaceutics AG | -11.8 Million USD | -2168.337% |
| Dermata Therapeutics, Inc. | -8.04 Million USD | -3230.355% |
| Aridis Pharmaceuticals, Inc. | -29.99 Million USD | -792.955% |
| Gritstone bio, Inc. | -154.63 Million USD | -73.199% |
| Jasper Therapeutics, Inc. | -68.86 Million USD | -288.934% |
| TNF Pharmaceuticals, Inc. | -17.12 Million USD | -1464.114% |
| Avid Bioservices, Inc. | -18.67 Million USD | -1333.901% |
| Insmed Incorporated | -709.62 Million USD | 62.258% |
| Virpax Pharmaceuticals, Inc. | -15.68 Million USD | -1606.996% |
| MediWound Ltd. | -15.29 Million USD | -1651.629% |
| OmniAb, Inc. | -69.41 Million USD | -285.808% |
| Alector, Inc. | -151.74 Million USD | -76.502% |
| Seres Therapeutics, Inc. | -107.98 Million USD | -148.024% |
| Checkpoint Therapeutics, Inc. | -52.14 Million USD | -413.584% |
| Zai Lab Limited | -366.57 Million USD | 26.938% |
| Revance Therapeutics, Inc. | -316.77 Million USD | 15.453% |
| Aura Biosciences, Inc. | -84.99 Million USD | -215.12% |
| Lyell Immunopharma, Inc. | -245.49 Million USD | -9.094% |
| Immunic, Inc. | -99.22 Million USD | -169.921% |
| Tarsus Pharmaceuticals, Inc. | -143.15 Million USD | -87.083% |
| Veracyte, Inc. | -85.79 Million USD | -212.167% |
| InMed Pharmaceuticals Inc. | - USD | Infinity% |
| FibroGen, Inc. | -281.81 Million USD | 4.965% |
| SeaStar Medical Holding Corporation | -14.21 Million USD | -1784.757% |
| Adial Pharmaceuticals, Inc. | -6.88 Million USD | -3788.299% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.79 Million USD | -1325.155% |
| Jazz Pharmaceuticals plc | 578.58 Million USD | 146.29% |
| Cyclacel Pharmaceuticals, Inc. | -25.45 Million USD | -952.23% |
| Amylyx Pharmaceuticals, Inc. | 38.8 Million USD | 790.232% |
| TG Therapeutics, Inc. | 20.63 Million USD | 1398.037% |
| Galecto, Inc. | -39.9 Million USD | -571.154% |
| Calithera Biosciences, Inc. | -42.07 Million USD | -536.555% |
| Fortrea Holdings Inc. | 63.1 Million USD | 524.444% |
| KalVista Pharmaceuticals, Inc. | -140.44 Million USD | -90.697% |
| Aptevo Therapeutics Inc. | -28.87 Million USD | -827.433% |
| XBiotech Inc. | -37.51 Million USD | -614.007% |
| Jasper Therapeutics, Inc. | -68.86 Million USD | -288.934% |
| Lyra Therapeutics, Inc. | -67.12 Million USD | -299.023% |
| Foghorn Therapeutics Inc. | -107.9 Million USD | -148.201% |
| Y-mAbs Therapeutics, Inc. | -25.67 Million USD | -943.253% |
| Theravance Biopharma, Inc. | -53.29 Million USD | -402.559% |
| Ultragenyx Pharmaceutical Inc. | -569.2 Million USD | 52.948% |
| Metagenomi, Inc. Common Stock | -78.49 Million USD | -241.212% |
| Vaxxinity, Inc. | -58.28 Million USD | -359.508% |
| BioCryst Pharmaceuticals, Inc. | -103.7 Million USD | -158.246% |
| Gain Therapeutics, Inc. | -22.25 Million USD | -1103.534% |
| Cartesian Therapeutics, Inc. | -86.41 Million USD | -209.924% |
| NexImmune, Inc. | -29.19 Million USD | -817.442% |
| Creative Medical Technology Holdings, Inc. | -5.62 Million USD | -4665.44% |
| Marker Therapeutics, Inc. | -14.58 Million USD | -1736.754% |
| Regeneron Pharmaceuticals, Inc. | 4.04 Billion USD | 106.618% |
| Chemomab Therapeutics Ltd. | -25.45 Million USD | -951.982% |
| Scopus BioPharma Inc. | -11.71 Million USD | -2186.187% |
| RAPT Therapeutics, Inc. | -127.06 Million USD | -110.782% |
| Ainos, Inc. | -13.2 Million USD | -1927.987% |
| Pluri Inc. | -22.15 Million USD | -1108.701% |
| Prothena Corporation plc | -191.03 Million USD | -40.196% |
| Adaptimmune Therapeutics plc | -138.03 Million USD | -94.022% |
| Celularity Inc. | -192.28 Million USD | -39.283% |
| Rallybio Corporation | -78.93 Million USD | -239.31% |
| Cue Biopharma, Inc. | -52.14 Million USD | -413.575% |
| MeiraGTx Holdings plc | -137.06 Million USD | -95.405% |
| Omeros Corporation | -164.53 Million USD | -62.781% |
| Humacyte, Inc. | -100.04 Million USD | -167.698% |
| Immunocore Holdings plc | -59.64 Million USD | -349.0% |
| Cocrystal Pharma, Inc. | -18.55 Million USD | -1343.095% |
| Cidara Therapeutics, Inc. | -24.48 Million USD | -993.918% |
| Blueprint Medicines Corporation | -486.27 Million USD | 44.924% |
| CalciMedica, Inc. | -21.87 Million USD | -1124.338% |
| Cabaletta Bio, Inc. | -74.66 Million USD | -258.725% |
| Marinus Pharmaceuticals, Inc. | -131.48 Million USD | -103.692% |
| Scholar Rock Holding Corporation | -171.29 Million USD | -56.352% |
| Sana Biotechnology, Inc. | -326.9 Million USD | 18.072% |
| Pulmatrix, Inc. | -14.74 Million USD | -1716.988% |
| Elicio Therapeutics, Inc. | -35.74 Million USD | -649.263% |
| Vigil Neuroscience, Inc. | -88.86 Million USD | -201.38% |
| Intellia Therapeutics, Inc. | -515.29 Million USD | 48.025% |
| Adlai Nortye Ltd. American Depositary Shares | -67.55 Million USD | -296.477% |
| Cytokinetics, Incorporated | -496.2 Million USD | 46.026% |
| Eloxx Pharmaceuticals, Inc. | -34.41 Million USD | -678.128% |
| Nutriband Inc. | -4.87 Million USD | -5397.292% |
| Protara Therapeutics, Inc. | -43.61 Million USD | -514.092% |
| Vor Biopharma Inc. | -126.03 Million USD | -112.498% |
| Roivant Sciences Ltd. | 4.24 Billion USD | 106.314% |
| Evogene Ltd. | -26.39 Million USD | -914.831% |
| ProKidney Corp. | -151.52 Million USD | -76.756% |
| Applied Therapeutics, Inc. | -64.53 Million USD | -315.006% |
| Hoth Therapeutics, Inc. | -7.69 Million USD | -3381.742% |
| BridgeBio Pharma, Inc. | -607.37 Million USD | 55.904% |
| CorMedix Inc. | -48.95 Million USD | -447.051% |
| BioLineRx Ltd. | -49.69 Million USD | -438.946% |
| Tango Therapeutics, Inc. | -114.17 Million USD | -134.577% |
| Galectin Therapeutics Inc. | -38.07 Million USD | -603.467% |
| Atai Life Sciences N.V. | -125.47 Million USD | -113.455% |
| Renovaro Biosciences Inc. | -81.63 Million USD | -228.058% |
| Aerovate Therapeutics, Inc. | -81.4 Million USD | -228.986% |
| Zentalis Pharmaceuticals, Inc. | -248.98 Million USD | -7.565% |
| Sagimet Biosciences Inc. | -30.74 Million USD | -771.256% |
| MediciNova, Inc. | -9.9 Million USD | -2605.221% |
| Praxis Precision Medicines, Inc. | -126.37 Million USD | -111.931% |
| Cardio Diagnostics Holdings, Inc. | -7.24 Million USD | -3597.971% |
| GeoVax Labs, Inc. | -26.74 Million USD | -901.476% |
| Axsome Therapeutics, Inc. | -231.82 Million USD | -15.529% |
| Biomea Fusion, Inc. | -126.13 Million USD | -112.331% |
| PTC Therapeutics, Inc. | -349.4 Million USD | 23.348% |
| Mereo BioPharma Group plc | -28.41 Million USD | -842.511% |
| Cullinan Oncology, Inc. | -191.08 Million USD | -40.157% |
| Syndax Pharmaceuticals, Inc. | -229.95 Million USD | -16.469% |
| Absci Corporation | -115.51 Million USD | -131.852% |
| NRx Pharmaceuticals, Inc. | -27.58 Million USD | -870.834% |
| 4D Molecular Therapeutics, Inc. | -112.86 Million USD | -137.292% |
| Dyne Therapeutics, Inc. | -242.16 Million USD | -10.597% |
| Kiniksa Pharmaceuticals, Ltd. | -25.19 Million USD | -962.962% |
| Ventyx Biosciences, Inc. | -207.99 Million USD | -28.765% |
| Allakos Inc. | -196.05 Million USD | -36.606% |
| Imunon, Inc. | -21.03 Million USD | -1173.507% |
| Fulcrum Therapeutics, Inc. | -110.66 Million USD | -142.015% |
| Corcept Therapeutics Incorporated | 107.28 Million USD | 349.645% |
| BioAtla, Inc. | -129.68 Million USD | -106.516% |
| NLS Pharmaceutics AG | -11.8 Million USD | -2168.337% |
| Bio-Path Holdings, Inc. | -15.84 Million USD | -1590.488% |
| Allogene Therapeutics, Inc. | -327.73 Million USD | 18.281% |
| Larimar Therapeutics, Inc. | -41.75 Million USD | -541.372% |
| XOMA Corporation | -41.84 Million USD | -539.992% |
| Kezar Life Sciences, Inc. | -105.23 Million USD | -154.496% |
| Cara Therapeutics, Inc. | -121.49 Million USD | -120.44% |
| aTyr Pharma, Inc. | -54.91 Million USD | -387.671% |
| Aligos Therapeutics, Inc. | -87.42 Million USD | -206.34% |
| Akero Therapeutics, Inc. | -172.87 Million USD | -54.928% |
| Viridian Therapeutics, Inc. | -254.45 Million USD | -5.256% |
| Eliem Therapeutics, Inc. | -21.46 Million USD | -1147.666% |
| EyeGate Pharmaceuticals, Inc. | -8.21 Million USD | -3161.074% |
| Akari Therapeutics, Plc | -16.8 Million USD | -1493.621% |
| Tevogen Bio Holdings Inc. | -8843.03 USD | -3028545.159% |
| Halozyme Therapeutics, Inc. | 337.57 Million USD | 179.338% |
| Lexaria Bioscience Corp. | -6.53 Million USD | -3998.915% |
| UroGen Pharma Ltd. | -65.53 Million USD | -308.667% |
| Sutro Biopharma, Inc. | -89.27 Million USD | -199.989% |
| ZIVO Bioscience, Inc. | -7.26 Million USD | -3587.506% |
| Orgenesis Inc. | -53.63 Million USD | -399.336% |
| Entera Bio Ltd. | -8.89 Million USD | -2912.305% |
| GH Research PLC | -41.22 Million USD | -549.711% |
| Lisata Therapeutics, Inc. | -25.7 Million USD | -941.792% |
| Reneo Pharmaceuticals, Inc. | -83.05 Million USD | -222.474% |
| Xencor, Inc. | -138.63 Million USD | -93.181% |
| 60 Degrees Pharmaceuticals, Inc. | -5.15 Million USD | -5095.842% |
| Replimune Group, Inc. | -234.77 Million USD | -14.078% |
| Coeptis Therapeutics Holdings, Inc. | -21.49 Million USD | -1146.208% |
| Vanda Pharmaceuticals Inc. | -13.95 Million USD | -1819.61% |
| Lexaria Bioscience Corp. | -6.53 Million USD | -3998.915% |
| Portage Biotech Inc. | -18.25 Million USD | -1367.288% |
| Cardio Diagnostics Holdings, Inc. | -7.24 Million USD | -3597.971% |
| Olema Pharmaceuticals, Inc. | -104.96 Million USD | -155.165% |
| OncoCyte Corporation | -25.13 Million USD | -965.5% |
| Qualigen Therapeutics, Inc. | -11.3 Million USD | -2269.106% |
| Processa Pharmaceuticals, Inc. | -11.45 Million USD | -2237.633% |
| Purple Biotech Ltd. | 22.27 Million USD | 1302.568% |
| CollPlant Biotechnologies Ltd. | -7.51 Million USD | -3465.282% |
| scPharmaceuticals Inc. | -55.39 Million USD | -383.472% |
| ProMIS Neurosciences, Inc. | -18.89 Million USD | -1317.231% |
| HilleVax, Inc. | -133.34 Million USD | -100.85% |
| NeuroSense Therapeutics Ltd. | -12.04 Million USD | -2122.79% |
| Tharimmune, Inc. | -9.45 Million USD | -2732.552% |
| Genprex, Inc. | -31.07 Million USD | -761.847% |
| Neumora Therapeutics, Inc. Common Stock | -188.19 Million USD | -42.313% |
| Atossa Therapeutics, Inc. | -31.37 Million USD | -753.568% |
| XTL Biopharmaceuticals Ltd. | -765 Thousand USD | -34909.673% |
| Virios Therapeutics, Inc. | -5.44 Million USD | -4816.982% |
| OKYO Pharma Limited | -15.74 Thousand USD | -1700398.993% |
| Savara Inc. | -60 Million USD | -346.321% |
| Curis, Inc. | -48.33 Million USD | -454.134% |
| Daré Bioscience, Inc. | -30.83 Million USD | -768.434% |
| Carmell Therapeutics Corporation | -5.21 Million USD | -5033.403% |
| Titan Pharmaceuticals, Inc. | -7.27 Million USD | -3580.418% |
| Achieve Life Sciences, Inc. | -27.25 Million USD | -882.84% |
| BeiGene, Ltd. | -1.2 Billion USD | 77.824% |
| Kiromic BioPharma, Inc. | -19.93 Million USD | -1243.197% |
| Revolution Medicines, Inc. Warrant | -487.18 Million USD | 45.026% |
| Protagonist Therapeutics, Inc. | -93.65 Million USD | -185.978% |
| Erasca, Inc. | -141.52 Million USD | -89.241% |
| bluebird bio, Inc. | -244.26 Million USD | -9.646% |
| Protagenic Therapeutics, Inc. | -4.52 Million USD | -5816.182% |
| BioMarin Pharmaceutical Inc. | 194.44 Million USD | 237.74% |
| DBV Technologies S.A. | -76.43 Million USD | -250.408% |
| Protagenic Therapeutics, Inc. | -4.52 Million USD | -5816.182% |
| Moderna, Inc. | -4.23 Billion USD | 93.682% |
| Vincerx Pharma, Inc. | -42.6 Million USD | -528.562% |
| Fresh Tracks Therapeutics, Inc. | -6.36 Million USD | -4111.069% |
| Molecular Templates, Inc. | -10.46 Million USD | -2458.991% |
| Acrivon Therapeutics, Inc. Common Stock | -67.23 Million USD | -298.328% |
| Travere Therapeutics, Inc. | -376.74 Million USD | 28.911% |
| Monte Rosa Therapeutics, Inc. | -143.31 Million USD | -86.883% |
| Spruce Biosciences, Inc. | -51.99 Million USD | -415.115% |
| Celldex Therapeutics, Inc. | -154.54 Million USD | -73.302% |
| Cogent Biosciences, Inc. | -208.13 Million USD | -28.681% |
| MacroGenics, Inc. | -168.24 Million USD | -59.188% |
| RenovoRx, Inc. | -11.39 Million USD | -2250.158% |
| Adicet Bio, Inc. | -152.03 Million USD | -76.156% |
| Prime Medicine, Inc. | -191.29 Million USD | -40.008% |
| Aditxt, Inc. | -26.06 Million USD | -927.625% |
| Adagene Inc. | -23.71 Million USD | -1029.113% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -3563.754% |
| Quantum-Si incorporated | -111.17 Million USD | -140.912% |
| Maravai LifeSciences Holdings, Inc. | -31.64 Million USD | -746.259% |
| Acurx Pharmaceuticals, Inc. | -14.57 Million USD | -1737.209% |
| Voyager Therapeutics, Inc. | 122.01 Million USD | 319.503% |
| SciSparc Ltd. | -5.77 Million USD | -4539.252% |
| Vericel Corporation | -6.46 Million USD | -4043.317% |
| Revelation Biosciences, Inc. | -8.65 Million USD | -2993.848% |
| Minerva Neurosciences, Inc. | -23.11 Million USD | -1058.43% |
| Generation Bio Co. | -138.56 Million USD | -93.287% |
| Astria Therapeutics, Inc. | -83.03 Million USD | -222.563% |
| Black Diamond Therapeutics, Inc. | -86.46 Million USD | -209.766% |
| Arcutis Biotherapeutics, Inc. | -241.1 Million USD | -11.084% |
| Invivyd, Inc. | -207.78 Million USD | -28.896% |
| Relay Therapeutics, Inc. | -373 Million USD | 28.197% |
| Quoin Pharmaceuticals, Ltd. | -9.37 Million USD | -2755.722% |
| Spero Therapeutics, Inc. | 21.48 Million USD | 1346.795% |
| Artelo Biosciences, Inc. | -10.28 Million USD | -2503.519% |
| 2seventy bio, Inc. | -216.7 Million USD | -23.59% |
| ADMA Biologics, Inc. | 21.63 Million USD | 1338.092% |
| Clene Inc. | -40.54 Million USD | -560.641% |
| Capricor Therapeutics, Inc. | -24.07 Million USD | -1012.325% |
| Boundless Bio, Inc. Common Stock | -54.79 Million USD | -388.766% |
| GeoVax Labs, Inc. | -26.74 Million USD | -901.476% |
| Recursion Pharmaceuticals, Inc. | -350.06 Million USD | 23.492% |
| Citius Pharmaceuticals, Inc. | -36.73 Million USD | -629.13% |
| Contineum Therapeutics, Inc. Class A Common Stock | 16.07 Million USD | 1765.883% |
| Relmada Therapeutics, Inc. | -103.7 Million USD | -158.263% |
| Finch Therapeutics Group, Inc. | -34 Million USD | -687.671% |
| ALX Oncology Holdings Inc. | -170.27 Million USD | -57.286% |
| Vir Biotechnology, Inc. | -684.3 Million USD | 60.862% |
| Evaxion Biotech A/S | -22.19 Million USD | -1106.577% |
| Ocular Therapeutix, Inc. | -82.38 Million USD | -225.1% |
| Verve Therapeutics, Inc. | -223.12 Million USD | -20.034% |
| Trevena, Inc. | -35.28 Million USD | -658.966% |
| Surrozen, Inc. | -45.78 Million USD | -485.024% |
| Tyra Biosciences, Inc. | -79.94 Million USD | -235.01% |
| Cingulate Inc. | -22.75 Million USD | -1076.773% |
| Galmed Pharmaceuticals Ltd. | 7.49 Million USD | 3674.8% |
| Unity Biotechnology, Inc. | -44.66 Million USD | -499.601% |
| Tenax Therapeutics, Inc. | -8.23 Million USD | -3152.683% |
| Terns Pharmaceuticals, Inc. | -102.55 Million USD | -161.144% |
| ACADIA Pharmaceuticals Inc. | -73.37 Million USD | -264.987% |
| Connect Biopharma Holdings Limited | -62.07 Million USD | -331.459% |
| Clearmind Medicine Inc. | -8.74 Million USD | -2963.875% |
| Kronos Bio, Inc. | -121.83 Million USD | -119.834% |
| Bolt Biotherapeutics, Inc. | -76.19 Million USD | -251.494% |
| CERo Therapeutics Holdings, Inc. | -2.93 Million USD | -9031.448% |
| Viking Therapeutics, Inc. | -100.82 Million USD | -165.627% |
| Statera Biopharma, Inc. | -98.34 Million USD | -172.334% |
| ImmunityBio, Inc. | -362.25 Million USD | 26.067% |
| Korro Bio, Inc. | -84.53 Million USD | -216.824% |
| Kineta, Inc. | -15.72 Million USD | -1603.39% |
| BioVie Inc. | -32.17 Million USD | -732.279% |
| Codexis, Inc. | -68.06 Million USD | -293.46% |
| Celularity Inc. | -192.28 Million USD | -39.283% |
| Crinetics Pharmaceuticals, Inc. | -222.6 Million USD | -20.312% |
| Celcuity Inc. | -66.23 Million USD | -304.383% |
| Virax Biolabs Group Limited | -6.49 Million USD | -4022.606% |
| Cibus, Inc. | -318.88 Million USD | 16.012% |
| Eledon Pharmaceuticals, Inc. | -43 Million USD | -522.847% |
| eFFECTOR Therapeutics, Inc. | -33.84 Million USD | -691.349% |
| IN8bio, Inc. | -30.33 Million USD | -782.83% |
| Kodiak Sciences Inc. | -277.32 Million USD | 3.425% |
| Annexon, Inc. | -143.72 Million USD | -86.347% |
| Adverum Biotechnologies, Inc. | -123.79 Million USD | -116.352% |
| Assembly Biosciences, Inc. | -64.64 Million USD | -314.293% |
| Avalo Therapeutics, Inc. | -23.44 Million USD | -1042.399% |
| Ionis Pharmaceuticals, Inc. | -353.73 Million USD | 24.286% |
| Eyenovia, Inc. | -25.4 Million USD | -954.158% |
| Puma Biotechnology, Inc. | 32.64 Million USD | 920.539% |
| Conduit Pharmaceuticals Inc. | -5.56 Million USD | -4715.246% |
| Xilio Therapeutics, Inc. | -79.13 Million USD | -238.448% |
| Arcellx, Inc. | -89.88 Million USD | -197.98% |
| Cardiff Oncology, Inc. | -45.41 Million USD | -489.765% |
| Enanta Pharmaceuticals, Inc. | -137.2 Million USD | -95.197% |
| Regulus Therapeutics Inc. | -31.1 Million USD | -760.921% |
| Moolec Science SA | -6.65 Million USD | -3925.125% |
| Acumen Pharmaceuticals, Inc. | -61.13 Million USD | -338.065% |
| Geron Corporation | -193.94 Million USD | -38.093% |
| LAVA Therapeutics N.V. | -43.25 Million USD | -519.203% |
| Royalty Pharma plc | 1.49 Billion USD | 117.949% |
| Atea Pharmaceuticals, Inc. | -164.16 Million USD | -63.146% |
| Greenwich LifeSciences, Inc. | -9.32 Million USD | -2771.225% |
| TFF Pharmaceuticals, Inc. | -21.89 Million USD | -1123.239% |
| Mersana Therapeutics, Inc. | -170.95 Million USD | -56.662% |
| Humacyte, Inc. | -100.04 Million USD | -167.698% |
| Structure Therapeutics Inc. | -102.77 Million USD | -160.593% |
| 89bio, Inc. | -151.2 Million USD | -77.128% |
| PMV Pharmaceuticals, Inc. | -80.13 Million USD | -234.229% |
| Avenue Therapeutics, Inc. | -14.54 Million USD | -1741.981% |
| Genelux Corporation | -24.16 Million USD | -1008.314% |
| Trevi Therapeutics, Inc. | -33.92 Million USD | -689.506% |
| Lexicon Pharmaceuticals, Inc. | -171.75 Million USD | -55.938% |
| Notable Labs, Ltd. | -14.65 Million USD | -1727.277% |
| Liquidia Corporation | -73.38 Million USD | -264.962% |
| Mustang Bio, Inc. | -50.72 Million USD | -427.982% |
| Immunovant, Inc. | -282.7 Million USD | 5.265% |
| Quantum-Si incorporated | -111.17 Million USD | -140.912% |
| Arbutus Biopharma Corporation | -78.1 Million USD | -242.911% |
| DiaMedica Therapeutics Inc. | -21.26 Million USD | -1159.341% |
| Vera Therapeutics, Inc. | -102.01 Million USD | -162.542% |
| Acasti Pharma Inc. | -11.31 Million USD | -2267.61% |
| MiNK Therapeutics, Inc. | -22.92 Million USD | -1068.46% |
| Pasithea Therapeutics Corp. | -15.97 Million USD | -1576.062% |
| Xenon Pharmaceuticals Inc. | -214.05 Million USD | -25.12% |
| Elevai Labs, Inc. Common Stock | -3.66 Million USD | -7199.502% |
| NeuroBo Pharmaceuticals, Inc. | -15.88 Million USD | -1585.912% |
| Tempest Therapeutics, Inc. | -29.15 Million USD | -818.558% |
| Soleno Therapeutics, Inc. | -41.38 Million USD | -547.168% |
| PepGen Inc. | -84.76 Million USD | -215.957% |
| Moleculin Biotech, Inc. | -29.63 Million USD | -803.864% |
| United Therapeutics Corporation | 1.18 Billion USD | 122.603% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | -1069.69% |
| Solid Biosciences Inc. | -104.31 Million USD | -156.745% |
| BriaCell Therapeutics Corp. | -32.8 Million USD | -716.335% |
| Immuneering Corporation | -58.41 Million USD | -358.502% |
| Lixte Biotechnology Holdings, Inc. | -5.09 Million USD | -5161.524% |
| Silo Pharma, Inc. | -3.85 Million USD | -6846.378% |
| Belite Bio, Inc | -31.66 Million USD | -745.724% |
| XOMA Corporation | -41.84 Million USD | -539.992% |
| ARS Pharmaceuticals, Inc. | -67.52 Million USD | -296.659% |
| Bionomics Limited | -17.89 Billion USD | 98.503% |
| Apogee Therapeutics, Inc. | -93 Million USD | -187.974% |
| Alpha Tau Medical Ltd. | 35.68 Million USD | 850.628% |
| uniQure N.V. | -282.87 Million USD | 5.319% |
| Cassava Sciences, Inc. | -105.95 Million USD | -152.767% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -3563.754% |
| Poseida Therapeutics, Inc. | -129.5 Million USD | -106.808% |
| Forte Biosciences, Inc. | -32.48 Million USD | -724.429% |
| Anebulo Pharmaceuticals, Inc. | -8.3 Million USD | -3123.395% |
| Enlivex Therapeutics Ltd. | -29.39 Million USD | -811.121% |
| Conduit Pharmaceuticals Inc. | -5.56 Million USD | -4715.246% |
| SeaStar Medical Holding Corporation | -14.21 Million USD | -1784.757% |
| FibroBiologics, Inc. Common Stock | -8.88 Million USD | -2912.982% |
| Altimmune, Inc. | -95.92 Million USD | -179.19% |
| Amicus Therapeutics, Inc. | -73.49 Million USD | -264.416% |
| Alpha Tau Medical Ltd. | 35.68 Million USD | 850.628% |
| Compugen Ltd. | -12.99 Million USD | -1961.453% |
| Peak Bio, Inc. | -1356.23 USD | -19747582.915% |
| Zevra Therapeutics, Inc. | -49.6 Million USD | -439.924% |
| Benitec Biopharma Inc. | -22.49 Million USD | -1090.858% |
| Spyre Therapeutics, Inc. | -242.3 Million USD | -10.533% |
| NKGen Biotech, Inc. Common Stock | -29.74 Million USD | -800.37% |
| Zura Bio Limited | -62.63 Million USD | -327.574% |
| PolyPid Ltd. | -22.86 Million USD | -1071.225% |
| Aileron Therapeutics, Inc. | -16.27 Million USD | -1545.515% |
| NKGen Biotech, Inc. Warrants | -29.74 Million USD | -800.37% |
| Instil Bio, Inc. | -159.16 Million USD | -68.264% |
| argenx SE | -425.04 Million USD | 36.99% |
| Immunome, Inc. | -109.53 Million USD | -144.521% |
| Compass Therapeutics, Inc. | -50.36 Million USD | -431.787% |
| Verona Pharma plc | -67.83 Million USD | -294.841% |
| enGene Holdings Inc. Warrants | -26.06 Million USD | -927.721% |
| Shattuck Labs, Inc. | -91.95 Million USD | -191.249% |
| CervoMed Inc. | -7.81 Million USD | -3327.974% |
| LENZ Therapeutics, Inc. | -73.11 Million USD | -266.33% |
| Plus Therapeutics, Inc. | -13.32 Million USD | -1910.54% |
| Dianthus Therapeutics, Inc. | -48.17 Million USD | -455.951% |
| Moolec Science SA | -6.65 Million USD | -3925.125% |
| Enveric Biosciences, Inc. | -16.44 Million USD | -1528.264% |
| Inovio Pharmaceuticals, Inc. | -135.22 Million USD | -98.056% |
| AnaptysBio, Inc. | -164.41 Million USD | -62.899% |
| Design Therapeutics, Inc. | -78.19 Million USD | -242.53% |
| Leap Therapeutics, Inc. | -87.04 Million USD | -207.699% |
| NeurAxis, Inc. | -6.66 Million USD | -3918.669% |
| Seelos Therapeutics, Inc. | -40.49 Million USD | -561.31% |
| Lumos Pharma, Inc. | -36.61 Million USD | -631.48% |
| Achilles Therapeutics plc | -75.25 Million USD | -255.889% |
| enGene Holdings Inc. Common Stock | -26.06 Million USD | -927.721% |
| 180 Life Sciences Corp. | -13.47 Million USD | -1887.193% |
| Opiant Pharmaceuticals, Inc. | 5.15 Million USD | 5294.101% |
| CERo Therapeutics Holdings, Inc. | -2.93 Million USD | -9031.448% |
| Nutriband Inc. | -4.87 Million USD | -5397.292% |
| ORIC Pharmaceuticals, Inc. | -110.78 Million USD | -141.762% |
| CG Oncology, Inc. Common stock | -55.44 Million USD | -383.01% |
| Fractyl Health, Inc. Common Stock | -50.83 Million USD | -426.839% |
| Rani Therapeutics Holdings, Inc. | -66.09 Million USD | -305.186% |
| MoonLake Immunotherapeutics | -54.12 Million USD | -394.842% |
| Palisade Bio, Inc. | -13.07 Million USD | -1949.151% |
| Tourmaline Bio, Inc. | -45.4 Million USD | -489.804% |
| Beam Therapeutics Inc. | -176.48 Million USD | -51.755% |
| Neurogene Inc. | -55.58 Million USD | -381.845% |
| Mirum Pharmaceuticals, Inc. | -109.15 Million USD | -145.363% |
| AEON Biopharma, Inc. | -48.42 Million USD | -453.024% |
| CARGO Therapeutics, Inc. Common Stock | -96.71 Million USD | -176.935% |
| Sesen Bio, Inc. | -25.9 Million USD | -933.71% |
| Enliven Therapeutics, Inc. | -83.52 Million USD | -220.636% |
| Kiora Pharmaceuticals, Inc. | -12.58 Million USD | -2027.8% |
| Iovance Biotherapeutics, Inc. | -460.55 Million USD | 41.848% |
| Taysha Gene Therapies, Inc. | -72.43 Million USD | -269.723% |
| Athira Pharma, Inc. | -125.46 Million USD | -113.463% |
| Vaccinex, Inc. | -22.88 Million USD | -1070.304% |
| HCW Biologics Inc. | -25.71 Million USD | -941.421% |
| XOMA Corporation | -41.84 Million USD | -539.992% |
| Nektar Therapeutics | -137.42 Million USD | -94.887% |
| Arvinas, Inc. | -401.5 Million USD | 33.294% |
| Tevogen Bio Holdings Inc. | -8843.03 USD | -3028545.159% |
| Merus N.V. | -156.54 Million USD | -71.082% |
| Omega Therapeutics, Inc. | -100.26 Million USD | -167.127% |
| Quince Therapeutics, Inc. | -34.62 Million USD | -673.611% |
| Rezolute, Inc. | -70.42 Million USD | -280.308% |
| Clene Inc. | -40.54 Million USD | -560.641% |
| Indaptus Therapeutics, Inc. | -16.37 Million USD | -1535.219% |
| BeyondSpring Inc. | -23.11 Million USD | -1058.709% |
| Synlogic, Inc. | -55.16 Million USD | -385.531% |
| Allarity Therapeutics, Inc. | -17.92 Million USD | -1393.803% |
| Phio Pharmaceuticals Corp. | -10.82 Million USD | -2374.353% |
| Peak Bio, Inc. | -1356.23 USD | -19747582.915% |
| Werewolf Therapeutics, Inc. | -40.5 Million USD | -561.245% |
| Krystal Biotech, Inc. | -109.72 Million USD | -144.082% |
| Karyopharm Therapeutics Inc. | -129.53 Million USD | -106.75% |
| SpringWorks Therapeutics, Inc. | -343.01 Million USD | 21.92% |
| Lipella Pharmaceuticals Inc. | -4.74 Million USD | -5543.208% |
| MannKind Corporation | 8.67 Million USD | 3186.241% |
| Ikena Oncology, Inc. | -75.41 Million USD | -255.124% |
| Cyclerion Therapeutics, Inc. | -9.64 Million USD | -2676.241% |
| Gyre Therapeutics, Inc. | -67.23 Million USD | -298.37% |
| Gossamer Bio, Inc. | -183.75 Million USD | -45.747% |
| CohBar, Inc. | -12.38 Million USD | -2061.911% |
| Cognition Therapeutics, Inc. | -50.72 Million USD | -428.003% |
| NRx Pharmaceuticals, Inc. | -27.58 Million USD | -870.834% |
| Legend Biotech Corporation | -439.48 Million USD | 39.06% |
| Mural Oncology plc | -194.63 Million USD | -37.601% |
| Biora Therapeutics, Inc. | -67.14 Million USD | -298.886% |
| PaxMedica, Inc. Common Stock | -16.14 Million USD | -1558.839% |
| Disc Medicine, Inc. | -91.12 Million USD | -193.908% |
| Champions Oncology, Inc. | -7.35 Million USD | -3540.892% |
| REGENXBIO Inc. | -268.12 Million USD | 0.113% |
| Ensysce Biosciences, Inc. | -10.71 Million USD | -2398.781% |
| Anavex Life Sciences Corp. | -55.75 Million USD | -380.35% |
| Cellectar Biosciences, Inc. | -38.96 Million USD | -587.422% |
| Edgewise Therapeutics, Inc. | -114.35 Million USD | -134.2% |
| Vaxart, Inc. | -83.34 Million USD | -221.336% |
| PharmaCyte Biotech, Inc. | -8.52 Million USD | -3043.471% |
| Aldeyra Therapeutics, Inc. | -42.79 Million USD | -525.844% |
| Cellectis S.A. | -106.62 Million USD | -151.181% |
| Longeveron Inc. | -21.02 Million USD | -1173.594% |
| Repare Therapeutics Inc. | -116.22 Million USD | -130.438% |
| Inozyme Pharma, Inc. | -75.64 Million USD | -254.054% |
| Revolution Medicines, Inc. | -487.18 Million USD | 45.026% |
| Nymox Pharmaceutical Corporation | -6.65 Million USD | -3926.218% |
| Third Harmonic Bio, Inc. | -43.95 Million USD | -509.328% |
| ArriVent BioPharma, Inc. Common Stock | -74.59 Million USD | -259.062% |
| AN2 Therapeutics, Inc. | -69.63 Million USD | -284.611% |
| Anixa Biosciences, Inc. | -11.01 Million USD | -2332.331% |
| Vertex Pharmaceuticals Incorporated | 4.3 Billion USD | 106.218% |
| Denali Therapeutics Inc. | -196.69 Million USD | -36.159% |
| Revelation Biosciences, Inc. | -8.65 Million USD | -2993.848% |
| Veru Inc. | -93.78 Million USD | -185.581% |
| Corvus Pharmaceuticals, Inc. | -23.32 Million USD | -1048.03% |
| Cingulate Inc. | -22.75 Million USD | -1076.773% |
| Passage Bio, Inc. | -108.38 Million USD | -147.095% |
| Context Therapeutics Inc. | -25.07 Million USD | -968.193% |
| Exicure, Inc. | -14.99 Million USD | -1685.97% |
| Day One Biopharmaceuticals, Inc. | -206.06 Million USD | -29.971% |
| Oramed Pharmaceuticals Inc. | -40.59 Million USD | -559.698% |
| Scinai Immunotherapeutics Ltd. | -9.71 Million USD | -2656.26% |
| Rhythm Pharmaceuticals, Inc. | -184.35 Million USD | -45.275% |
| Nuvalent, Inc. | -149.49 Million USD | -79.156% |
| ABVC BioPharma, Inc. | -8.21 Million USD | -3159.584% |
| Carisma Therapeutics, Inc. | -88.73 Million USD | -201.838% |
| Unicycive Therapeutics, Inc. | -20.77 Million USD | -1189.227% |
| OmniAb, Inc. | -69.41 Million USD | -285.808% |
| Anew Medical, Inc. | -1.3 Million USD | -20488.543% |
| Fennec Pharmaceuticals Inc. | -12.77 Million USD | -1997.126% |
| Lipocine Inc. | -17.93 Million USD | -1393.64% |
| Lexeo Therapeutics, Inc. Common Stock | -68.51 Million USD | -290.91% |
| Nautilus Biotechnology, Inc. | -76.15 Million USD | -251.697% |
| SAB Biotherapeutics, Inc. | -38.07 Million USD | -603.406% |
| G1 Therapeutics, Inc. | -39.52 Million USD | -577.572% |
| Bellerophon Therapeutics, Inc. | -22.38 Million USD | -1096.497% |
| Sage Therapeutics, Inc. | -579.84 Million USD | 53.811% |
| Ocugen, Inc. | -65.53 Million USD | -308.698% |
| Mind Medicine (MindMed) Inc. | -93.86 Million USD | -185.326% |
| Q32 Bio Inc. | -92.1 Million USD | -190.791% |
| Brainstorm Cell Therapeutics Inc. | -21.43 Million USD | -1149.237% |
| Alumis Inc. Common Stock | -158.17 Million USD | -69.322% |
| Equillium, Inc. | -14.52 Million USD | -1744.264% |
| Kyverna Therapeutics, Inc. | -62.4 Million USD | -329.164% |
| Coya Therapeutics, Inc. | -7.9 Million USD | -3288.741% |
| CNS Pharmaceuticals, Inc. | -18.86 Million USD | -1319.679% |
| Galera Therapeutics, Inc. | -46.95 Million USD | -470.433% |
| Evelo Biosciences, Inc. | -108.46 Million USD | -146.92% |
| Comera Life Sciences Holdings, Inc. | -11.97 Million USD | -2137.458% |
| Dominari Holdings Inc. | -21.79 Million USD | -1128.776% |
| Edesa Biotech, Inc. | -9.22 Million USD | -2803.947% |
| vTv Therapeutics Inc. | -25.5 Million USD | -950.208% |
| Bio-Techne Corporation | 206.68 Million USD | 229.58% |
| Agios Pharmaceuticals, Inc. | -391.48 Million USD | 31.588% |
| Harmony Biosciences Holdings, Inc. | 192.03 Million USD | 239.47% |
| Prelude Therapeutics Incorporated | -132.27 Million USD | -102.472% |
| Candel Therapeutics, Inc. | -38.39 Million USD | -597.622% |
| iTeos Therapeutics, Inc. | -151.1 Million USD | -77.248% |
| Nkarta, Inc. | -131.65 Million USD | -103.436% |
| BioCardia, Inc. | -11.64 Million USD | -2200.103% |
| Iterum Therapeutics plc | -47.46 Million USD | -464.22% |